Ortho Launches Second COVID-19 Antibody Test With 100% Specificity
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today introduced and announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to its second COVID-19 antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test (COVID-19 IgG antibody test). This test is one of only a handful of antibody tests to be granted Emergency Use Authorization.
from Yahoo News - Latest News & Headlines https://ift.tt/2VCv4Ki
via IFTTT
Comments
Post a Comment